At an international AIDS conference in Washington, D.C., significant progress was announced today with HAART, the combination of three antiviral drugs. This progress is confirmed by the experiments carried out in the infectious diseases department of the Hôpital La Pitié Salpêtrière in Paris. The question of the cost of treatment is likely to be problematic, especially for Third World countries The commentary on images of consultations of AIDS patients in the hospital, and images of drug production in a pharmaceutical laboratory, alternates with interviews of François BRICAIRE, Head of the Infectious Diseases Department, Hospital La Pitié Salpêtrière, and Professor Jean-Paul LEVY, Director of the National Agency for AIDS Research.
Producteur: France 2 - Journalist : Marinet, Gilles - Participant : Bricaire, François - Participant : Levy, Jean Paul
Origin:
F2 The Journal 20H - Producteur: France 2
Licence:
Turnkey
×
Mediaclip turnkey licences
Accessible rights for all uses, in the whole world, in accordance with our T&Cs.
Digital Publication : use for editorial publications - to inform the general public or illustrate the news - for digital broadcast on services, valid for 5 years.
Corporate/Brand content : use for the presentation and promotion of an image, brand, history and values of the Contracting Partner company - or, where applicable, the Beneficiary - for digital broadcast on its services and/or for Events, valid for 1 year.
Cultural Licence : use for cultural purposes and restricted to members of the cultural network. Digital publication for a term of 5 (years) and Events for a term of 1 (one) year from the order payment date.
Reference:CAB96004770
Credits:Journalist : Marinet, Gilles-Participant : Bricaire, François-Participant : Levy, Jean Paul